Compare ALKS & FCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALKS | FCN |
|---|---|---|
| Founded | 1987 | 1982 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.0B |
| IPO Year | 2012 | 1996 |
| Metric | ALKS | FCN |
|---|---|---|
| Price | $27.66 | $162.26 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 1 |
| Target Price | $43.43 | ★ $165.00 |
| AVG Volume (30 Days) | ★ 1.7M | 551.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 5.51 |
| EPS | 1.43 | ★ 8.24 |
| Revenue | $1,475,899,000.00 | ★ $3,788,857,000.00 |
| Revenue This Year | $24.06 | $7.39 |
| Revenue Next Year | $4.53 | $7.10 |
| P/E Ratio | ★ $19.41 | $19.71 |
| Revenue Growth | N/A | ★ 2.44 |
| 52 Week Low | $25.17 | $149.31 |
| 52 Week High | $36.32 | $183.72 |
| Indicator | ALKS | FCN |
|---|---|---|
| Relative Strength Index (RSI) | 28.59 | 43.71 |
| Support Level | $25.65 | $155.22 |
| Resistance Level | $28.75 | $168.01 |
| Average True Range (ATR) | 1.09 | 5.68 |
| MACD | -0.38 | 0.36 |
| Stochastic Oscillator | 8.03 | 54.49 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.